跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASPIFOX 20 MG/100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ASPIFOX 20 MG/100 MG CAPSULAS DURAS
Approved
STANDARD
ASPIFOX 20 MG/100 MG CAPSULAS DURAS
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 7, 2020
Approval ID
f030d91de926e61f
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
f030d91de926e61f
Drug Cima Aemps Name
ASPIFOX 20 MG/100 MG CAPSULAS DURAS
Register Number
85381
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2020-09-07
Dosage Form
CÁPSULA DURA
Dose
20 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
ROSUVASTATINA CALCICA
20,8 mg
ACETILSALICILICO ACIDO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 7, 2020
Approval ID
f030d91de926e61f
Type
Standard
Back to CIMA-AEMPS Approvals
